Concepedia

Hiroki Hinata

HH

Statistics

Publications

2

Citations

26

H-Index

2

Active since

2020

Affiliations

Tokyo University of Pharmacy and Life Sciences(Current)

Hiroki Hinata is an author at Tokyo University of Pharmacy and Life Sciences specializing in cancer therapeutics, human growth, and tumor biology.

Top concepts

Publications per year

2020–2022

2

Publications

2

Combination therapy with anamorelin and a myostatin inhibitor is advantageous for cancer cachexia in a mouse model

Kako Hanada, Kunpei Fukasawa, Hiroki Hinata et al. · Cancer Science · 2022 · 16 citations · Full text

, , +23

The evolutionarily conserved deubiquitinase UBH1/UCH-L1 augments DAF7/TGF-β signaling, inhibits dauer larva formation, and enhances lung tumorigenesis

Asami Nagata, Fumiko Itoh, Ayaka Sasho et al. · Journal of Biological Chemistry · 2020 · 10 citations · Full text

1–2 of 2